circRNA basic information
circBase ID: hsa_circ_0000615
Name: hsa_circ_ZNF609
Synonym: circ-ZNF609
Host Gene: ZNF609
Genomic location(hg19): chr15:64791491-64792365:+
Genomic location(hg38): chr15:64499292-64500166:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0019087
MONDO name: cholangiocarcinoma
Disease details: cholangiocarcinoma
Disease DO ID:
4947
Disease MeSH ID:
D018281
Disease NCIt ID:
C4436
Disease ICD11 ID:
2110597275
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

CCA tissues; adjacent normal tissues

Cell lines:

HIBEC; CCLP-1; TFK-1; QBC939; RBE

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: LRRC1, YY1, eIF4A3, Ago2
Associated microRNA: miR-432-5p
Biological function: promotes proliferation, migration and invasion; promotes xenograft growth; promotes EMT
Molecular mechanism: circ-ZNF609 acts as a ceRNA to sponge miR-432-5p, relieving repression of LRRC1; YY1 promotes circ-ZNF609 transcription; eIF4A3 promotes circ-ZNF609 circular formation by binding its pre-mRNA
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); EMT (promotes); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); ChIP / ChIP-seq; Transfection; CCK8; EdU Staining; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Western Blot; In Vivo Animal Model; Survival Analysis; ROC Analysis; Bioinformatics Analysis; Clinical Sample Validation

Clinical significance:

High circ-ZNF609 expression was associated with advanced TNM stage, lymph node invasion, and inferior overall survival, and was an independent risk factor for unfavorable prognosis; ROC analysis supported prognostic biomarker potential.

Description:

circ-ZNF609 is up-regulated in cholangiocarcinoma and functions as an oncogenic circRNA that promotes proliferation, migration, invasion and xenograft growth. Mechanistically, it sponges miR-432-5p to up-regulate LRRC1, while YY1 enhances its transcription and eIF4A3 promotes its circularization by binding the pre-mRNA.

Confidence score:

0.849

Other information
Title:

YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1.

Journal: Aging
Published: 2021
PubMed ID: 34898474
Study type:

combined biological and clinical study

Data availability: -
Code availability: -